Product Description
Sofosvel is the global first generic oral tablet for pan-genotypic Chronic Hepatitis C treatment. The combination of (Sofosbuvir 400 mg + Valpatasvir 100 mg) drug has been approved by US FDA European Commission for treatment of patients with all genotypic Chronic Hepatitis C virus infection. Sofosvel is used without cirrhosis or with compensated cirrhosis and patients with advanced cirrhosis (Decompensated).